Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03DSX
|
||||
Former ID |
DCL000643
|
||||
Drug Name |
SSR411298
|
||||
Indication | Major depressive disorder [ICD9: 296.2, 296.3, 710.0; ICD10:F32, F33, M32] | Phase 2 | [522544] | ||
Company |
Sanofi-Aventis
|
||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [549823] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.